As of 2024-12-12, the Fair Value of Acerus Pharmaceuticals Corporation (ASP.TO) is -25.79 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.36 CAD, the upside of Acerus Pharmaceuticals Corporation is -7,263.99%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | -8.62 | -18.79 | -16.13 | -24.42 | -33.82 | -20.36 |
| YoY growth | -177.52% | -117.98% | 14.16% | -51.39% | -38.48% | -74.24% |
| Market Cap (mil) | 2.77 |
| P/E | |
| Forward P/E |
| EPS | -3.64 |
| Avg earnings growth rate | -74.24% |
| TTM earnings | -28.08 |